Table of Content
Introduction
Gaucher Disease - Overview
Gaucher Disease - Therapeutics Development
Gaucher Disease - Therapeutics Assessment
Gaucher Disease - Companies Involved in Therapeutics Development
Gaucher Disease - Drug Profiles
Gaucher Disease - Dormant Projects
Gaucher Disease - Discontinued Products
Gaucher Disease - Product Development Milestones
Appendix
List of Figures
Number of Products under Development for Gaucher Disease, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020
List of Tables
Number of Products under Development for Gaucher Disease, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Gaucher Disease - Pipeline by Adienne Pharma & Biotech, H1 2020
Gaucher Disease - Pipeline by Apollo Therapeutics LLC, H1 2020
Gaucher Disease - Pipeline by AVROBIO Inc, H1 2020
Gaucher Disease - Pipeline by Belrose Pharma Inc, H1 2020
Gaucher Disease - Pipeline by Bioasis Technologies Inc, H1 2020
Gaucher Disease - Pipeline by Biosidus SA, H1 2020
Gaucher Disease - Pipeline by Blue Turtle Bio Technologies Inc, H1 2020
Gaucher Disease - Pipeline by Erad Therapeutics Inc, H1 2020
Gaucher Disease - Pipeline by Evox Therapeutics Ltd, H1 2020
Gaucher Disease - Pipeline by Freeline Therapeutics Ltd, H1 2020
Gaucher Disease - Pipeline by Generation Bio Co, H1 2020
Gaucher Disease - Pipeline by Genzyme Corp, H1 2020
Gaucher Disease - Pipeline by GT Gain Therapeutics SA, H1 2020
Gaucher Disease - Pipeline by ILIAS Biologics Inc, H1 2020
Gaucher Disease - Pipeline by ISU ABXIS Co Ltd, H1 2020
Gaucher Disease - Pipeline by Johnson & Johnson, H1 2020
Gaucher Disease - Pipeline by M6P Therapeutics, H1 2020
Gaucher Disease - Pipeline by Orphazyme A/S, H1 2020
Gaucher Disease - Pipeline by Prevail Therapeutics Inc, H1 2020
Gaucher Disease - Pipeline by Sanofi, H1 2020
Gaucher Disease - Pipeline by SmartPharm Therapeutics Inc, H1 2020
Gaucher Disease - Pipeline by Takeda Pharmaceutical Co Ltd, H1 2020
Gaucher Disease - Pipeline by Vera Therapeutics Inc, H1 2020
Gaucher Disease - Pipeline by Yuhan Corp, H1 2020
Gaucher Disease - Dormant Projects, H1 2020
Gaucher Disease - Dormant Projects, H1 2020 (Contd..1), H1 2020
Gaucher Disease - Discontinued Products, H1 2020